Hydrops Fetalis
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Pediatrix TherapeuticsChina - Shanghai
1 programTandem MS test for inborn errors of metabolismN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Human BioSciencesExome sequencing
Pediatrix TherapeuticsTandem MS test for inborn errors of metabolism
Clinical Trials (2)
Total enrollment: 548 patients across 2 trials
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
Start: Oct 2018Est. completion: Feb 2027500 patients
N/AActive Not Recruiting
Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR
Start: Mar 2006Est. completion: Aug 200948 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.